TET2 c.302C>A ;(p.P101H)

Variant ID: 4-106155401-C-A

NM_001127208.2(TET2):c.302C>A;(p.P101H)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.

Communications Biology
Dong, Xiaobao X; Huang, Dandan D; Yi, Xianfu X; Zhang, Shijie S; Wang, Zhao Z; Yan, Bin B; Chung Sham, Pak P; Chen, Kexin K; Jun Li, Mulin M
Publication Date: 2020-01-07

Variant appearance in text: TET2: 302C>A; P101H
PubMed Link: 31925297
Variant Present in the following documents:
  • 42003_2019_736_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer.

Cell Research
Chen, Hao H; Yu, Dingdang D; Fang, Rui R; Rabidou, Kimberlie K; Wu, Di D; Hu, Di D; Jia, Peilin P; Zhao, Zhongming Z; Wu, Zhiping Z; Peng, Junmin J; Shi, Yang Y; Shi, Yujiang Geno YG
Publication Date: 2019-03

Variant appearance in text: TET2: P101H
PubMed Link: 30607016
Variant Present in the following documents:
  • Main text
View BVdb publication page



Feature-based classification of amino acid substitutions outside conserved functional protein domains.

Thescientificworldjournal
Gemovic, Branislava B; Perovic, Vladimir V; Glisic, Sanja S; Veljkovic, Nevena N
Publication Date: 2013

Variant appearance in text: TET2: P101H
PubMed Link: 24348198
Variant Present in the following documents:
  • 948617.f1.pdf
View BVdb publication page